Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp > Great time for Labs to use German news to their advantage
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(538)
•••
Comment by mdjbrownon Feb 26, 2024 10:43am
83 Views
Post# 35899022

RE:RE:RE:RE:Great time for Labs to use German news to their advantage

RE:RE:RE:RE:Great time for Labs to use German news to their advantageYou are much smarter than I Macpoor.  I was the not so proud bagholder of a million worthless Medipharm warrants at an avg of .05 cents, so needless to say I am counting on Medipharm getting its sh*t together in 2024 so losses can be recovered by all shareholders currently well under water.

I believe they are joining the right dots to make that happen albeit much slower than expected, but we will need to see Q4, and Q1 financials to get a better barometer of anticipated performance.

Good luck to all Labs shareholders as 2024 should be very telling............
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities